Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengyan Jin

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Blood Science (Baltimore, Md.)|October 3, 2024
Dynamic frailty-tailored therapy (DynaFiT): A proof-of-concept study in elderly patients with newly diagnosed multiple myelomaYun Dai, Fengyan Jin
Molecular Cancer Research : MCR|July 7, 2012
New insight into the SDF-1/CXCR4 axis in a breast carcinoma model: hypoxia-induced endothelial SDF-1 and tumor cell CXCR4 are required for tumor cell intravasationFengyan Jin, Ulf Brockmeier, Friedrich Otterbach, et al.
Blood Reviews|January 16, 2025
Mechanisms for resistance to BCMA-targeted immunotherapies in multiple myelomaTingting Yue, Yue Sun, Yun Dai, et al.
Expert Opinion on Therapeutic Targets|November 25, 2021
The mechanisms and therapeutic targets of ferroptosis in cancerLong Ye, Fengyan Jin, Shaji K Kumar, et al.
Blood Science (Baltimore, Md.)|April 11, 2022
Cell cycle regulation and hematologic malignanciesYun Dai, Fengyan Jin, Wei Wu, et al.
Oncology Letters|November 26, 2020
Erratum: Impact of microRNA-29b on nature killer cell in T-cell acute lymphoblastic leukemiaFengyan Jin, Zhonghua Du, Yang Tang, et al.
Oncology Letters|August 13, 2019
Impact of microRNA-29b on natural killer cells in T-cell acute lymphoblastic leukemiaFengyan Jin, Zhonghua Du, Yang Tang, et al.
Frontiers in Cardiovascular Medicine|April 15, 2022
Diverse Epigenetic Regulations of Macrophages in AtherosclerosisHongmei Yang, Yue Sun, Qingchao Li, et al.
Blood Reviews|August 13, 2021
Decoding DNA methylation in epigenetics of multiple myelomaTing Yang, Xiaobo Liu, Shaji K Kumar, et al.
Oncotargets and Therapy|October 8, 2015
Bioinformatics analyses of differentially expressed genes associated with bisphosphonate-related osteonecrosis of the jaw in patients with multiple myelomaJingnan Sun, Xue Wen, Fengyan Jin, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Blood Science (Baltimore, Md.)|October 3, 2024
Dynamic frailty-tailored therapy (DynaFiT): A proof-of-concept study in elderly patients with newly diagnosed multiple myelomaYun Dai, Fengyan Jin
Molecular Cancer Research : MCR|July 7, 2012
New insight into the SDF-1/CXCR4 axis in a breast carcinoma model: hypoxia-induced endothelial SDF-1 and tumor cell CXCR4 are required for tumor cell intravasationFengyan Jin, Ulf Brockmeier, Friedrich Otterbach, et al.
Blood Reviews|January 16, 2025
Mechanisms for resistance to BCMA-targeted immunotherapies in multiple myelomaTingting Yue, Yue Sun, Yun Dai, et al.
Expert Opinion on Therapeutic Targets|November 25, 2021
The mechanisms and therapeutic targets of ferroptosis in cancerLong Ye, Fengyan Jin, Shaji K Kumar, et al.
Blood Science (Baltimore, Md.)|April 11, 2022
Cell cycle regulation and hematologic malignanciesYun Dai, Fengyan Jin, Wei Wu, et al.
Oncology Letters|November 26, 2020
Erratum: Impact of microRNA-29b on nature killer cell in T-cell acute lymphoblastic leukemiaFengyan Jin, Zhonghua Du, Yang Tang, et al.
Oncology Letters|August 13, 2019
Impact of microRNA-29b on natural killer cells in T-cell acute lymphoblastic leukemiaFengyan Jin, Zhonghua Du, Yang Tang, et al.
Frontiers in Cardiovascular Medicine|April 15, 2022
Diverse Epigenetic Regulations of Macrophages in AtherosclerosisHongmei Yang, Yue Sun, Qingchao Li, et al.
Blood Reviews|August 13, 2021
Decoding DNA methylation in epigenetics of multiple myelomaTing Yang, Xiaobo Liu, Shaji K Kumar, et al.
Oncotargets and Therapy|October 8, 2015
Bioinformatics analyses of differentially expressed genes associated with bisphosphonate-related osteonecrosis of the jaw in patients with multiple myelomaJingnan Sun, Xue Wen, Fengyan Jin, et al.
Pageof 7